Viewing StudyNCT05927857



Ignite Creation Date: 2024-05-06 @ 7:12 PM
Last Modification Date: 2024-10-26 @ 3:02 PM
Study NCT ID: NCT05927857
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-07-03
First Post: 2023-06-14

Brief Title: Ramucirumab Cyramza Nal-IRI ONIVYDE and TrifluridineTipiracil Lonsurf in Second Line Metastatic Gastric Cancer
Sponsor: National Health Research Institutes Taiwan
Organization: National Health Research Institutes Taiwan

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-09-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-08-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2023-06-14
First Submit QC Date: June 25 2023
Study First Post Date: 2023-07-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-25
Last Update Post Date: 2023-07-03
Last Update Post Date Type: ACTUAL